Skip to content

Study · Non-randomized trial · n = 646 · 2010

1 result

[Neuropeptides in the treatment of optic nerve atrophy in children].

Guseva MR

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2010

PMID20517208 (opens in a new tab)PepBankPUB-20517208

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In children with partial optic nerve atrophy, Cerebrolysin showed an unspecified positive effect, particularly with subsequent optic nerve stimulation.

    In plain wordsIn children with partial optic nerve atrophy, Cerebrolysin showed an unspecified positive effect, particularly with subsequent optic nerve stimulation.

    Outcome
    Direction not reportedUnspecified therapeutic effect on partial optic nerve atrophy
    Study

    n = 646

    Outcome group
    Neuroprotection · Eye
    Studied dose
    0,1 ml per 1 kg daily intramuscularly and 0,3-0,5 ml retrobulbar · intramuscular and retrobulbarAs given in this study (human).

    Source sentences

    Summary
    The positive effect of the drug, in particular with the following optic nerve stimulation, has been shown.
    2 context sentences
    Summary · context
    Six hundreds and forty-six children aged from 8 weeks to 18 years have been studied.
    Summary · context
    Cerebrolysin was injected intramuscularly in dose 0,1 ml per 1 kg of body mass daily and retrobulbar in dose 0,3-0,5 ml; an irrigation system was used to treat a posterior segment of the eye.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.